iLoF is enabling a new era of personalized, precision medicine, by providing screening and stratification tools in an affordable, fast, portable way. Currently focusing a patented platform technology on the epidemic of our century: Alzheimer's disease.
WHAT: iLoF delivers an inexpensive, noninvasive way of stratifying patients for Alzheimer's clinical trials. Saving 40% of the total costs for screening and 70% of the time spent screening for clinical trials of Alzheimer's, crucial to enable a treatment for the disease.
HOW: Identifying gold-standard proteins and exosomes critical for the development of effective treatments, using a patented, portable, inexpensive photonics and Artificial Intelligence system.
WHY: After more than 14 years and 400 major trials failed, Alzheimer's trials need help. 90% of initial enrolled patients leave trials due to invasive, inconvenient screening, causing development of potentially effective drugs to be abandoned.
B2C, B2B
1 to 25
Seed
$3,203,679
Scaling Up
2019
Pharmaceuticals and Medical Products
Medical Practice
Managed Health Care
Healthcare
Health Care Facilities & Hospitals
Alternative Medicine
N/A
N/A
IT and Security
Service
Yes
Active
Machine Learning
Natural Language Processing
N/A
Software
Data Scientist/Machine Learning
Porto, Porto
Associate to the CEO
Porto, Porto
Cloud Engineer (Software | IoT )
Porto, Porto
AI/ML Professionals
Want to work at iLoF - Intelligent Lab on Fiber?
We can introduce you to the right person at iLoF - Intelligent Lab on Fiber
Potential Customers
Interested in what they do or partnership?
Learn more about how they work